Title : Deep molecular response by IFN-α and dasatinib combination in a patient with T315I-mutated chronic myeloid leukemia.

Pub. Date : 2016 Jul

PMID : 27347777






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 We present here a chronic myeloid leukemia patient harboring the T315I and E255V BCR-ABL1 mutation successfully achieved deep molecular response with a combined treatment of dasatinib and IFN-alpha. Dasatinib ABL proto-oncogene 1, non-receptor tyrosine kinase Homo sapiens